Japan Tissue Engineering Co., Ltd. (TSE: 7774)
Health Care · Biotechnology · JP
¥862.00
+2.13% today · +72.1% 1Y
Japan Tissue Engineering Co., Ltd. (TSE: 7774) operates in the Biotechnology industry within the Health Care sector. The company is valued at $220.20M and employs 200 people.
Over the last twelve months the share price has gained 72.1%, trading between 448.00 and 893.00.
Tweenvest scores Japan Tissue Engineering Co., Ltd. across four factors: quality 60/100, value 45/100, growth 0/100. Its strongest factor is quality.
7774 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $220.20M
- Revenue (TTM)
- $15.52M
- P/E
- —
- EPS
- -10.84
- Dividend yield
- —
- Beta (5Y)
- 0.63
- 52-week high
- ¥893.00
- 52-week low
- ¥448.00
- Avg volume (3M)
- —
- Shares outstanding
- 40.61M
- Employees
- 200
- Next earnings
- —
About Japan Tissue Engineering Co., Ltd.
Japan Tissue Engineering Co., Ltd. operates within the regenerative medicine sector in Japan. The company's activities are organized into three core divisions: Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support. It manufactures and delivers autologous cultured tissues, such as epidermis, cartilage, corneal epithelium, and oral mucosal epithelium, to medical institutions for therapeutic applications. The firm also produces other advanced tissue-engineered medical products. Furthermore, Japan Tissue Engineering is involved in the research and development of three-dimensional human cultured tissue models, which are utilized in the development of external-use cosmetics and drugs, as well as for scientific investigations concerning skin and corneal tissues. Additionally, the company provides comprehensive contract development and manufacturing services for regenerative medicine. Established in 1999, Japan Tissue Engineering Co., Ltd. is based in Gamagori, Japan, and functions as a subsidiary of Teijin Limited.
- ISIN
- JP3389610001
- Founded
- 1999
- Listed since
- Dec 28, 2007
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $464.58B | $262.90 | -1.09% |
| Amgen Inc.NasdaqGS: AMGN | $238.06B | $440.34 | -0.43% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $183.64B | $148.09 | -0.01% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.72B | $547.29 | -1.01% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $81.36B | $814.79 | -2.25% |
| argenx SEENXTBR: ARGX | $65.40B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $59.75B | $149.66 | -5.77% |
| CSL LimitedASX: CSL | $59.19B | AU$172.44 | -0.69% |
Figures last refreshed Aug 18, 2026.